Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Macmillan, S.
Right arrow Articles by Templeton, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macmillan, S.
Right arrow Articles by Templeton, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 12, 3009-3012, December 1999
© 1999 European Society of Human Reproduction and Embryology

Screening for Chlamydia trachomatis in subfertile women

Susan Macmillan1 and Allan Templeton

Department of Obstetrics and Gynaecology, University of Aberdeen, Aberdeen AB25 2ZD, UK

Chlamydia trachomatis is the most common sexually transmitted disease in the UK and Europe. The majority of female infections are asymptomatic and recognized sequelae include pelvic inflammatory disease, infertility, and ectopic pregnancy. Women with chlamydial infection who undergo uterine instrumentation are recognized to be at risk of ascending infection. Most patients attending for infertility investigations and treatment will undergo some form of uterine instrumentation. Published data regarding the prevalence of chlamydial infection in the subfertile are few and conflicting. In this study, more than 400 consecutive women presenting for infertility investigation and treatment at a single regional fertility centre were screened for Chlamydia. Half were screened using enzyme immunoassay (EIA) and half by ligase chain reaction (LCR). Prevalence by diagnostic test was 0% with EIA and 1.9% with LCR. Overall, the low prevalence was at least partly explained by older age. Until more evidence comes from studies testing consecutive subfertile patients both with EIA and a DNA amplification method such as LCR, centres using EIA should consider using prophylactic antibiotics prior to uterine instrumentation.

Key words: Chlamydia trachomatis/infertility/prevalence/screening/uterine instrumentation

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
J.A. Land, J.E.A.M. Van Bergen, S.A. Morre, and M.J. Postma
Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening
Hum. Reprod. Update, October 14, 2009; (2009) dmp035v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Hung, Y. Ng, C. S. W. Ngai, and P. C. Ho
Chlamydia trachomatis in infertile women undergoing uterine instrumentation: Screen or treat
Hum. Reprod., August 1, 2002; 17(8): 2215 - 2216.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Thomas and I. Simms
Chlamydia trachomatis in subfertile women undergoing uterine instrumentation: How we can help in the avoidance of iatrogenic pelvic inflammatory disease?
Hum. Reprod., June 1, 2002; 17(6): 1431 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. A. Land, A. P. Gijsen, J. L.H. Evers, and C. A. Bruggeman
Chlamydia trachomatis in subfertile women undergoing uterine instrumentation: Screen or treat?
Hum. Reprod., March 1, 2002; 17(3): 525 - 527.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. P. Gijsen, J. A. Land, V. J. Goossens, M. E.P. Slobbe, and C. A. Bruggeman
Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time
Hum. Reprod., March 1, 2002; 17(3): 699 - 703.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. H. Yu Ng, O. S. Tang, and P. C. Ho
Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis antibody in predicting tubal pathology at laparoscopy
Hum. Reprod., April 1, 2001; 16(4): 775 - 779.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.